Profile data is unavailable for this security.
About the company
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.
- Revenue in CAD (TTM)2.19m
- Net income in CAD-1.34m
- Incorporated--
- Employees--
- LocationLattice Biologics Ltd512 E. Madison Ave. Suite A1BELGRADE 59714United StatesUSA
- Phone+1 (406) 570-2658
- Fax+1 (480) 563-0810
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CardioComm Solutions Inc | 643.05k | -141.08k | 1.93m | 16.00 | -- | -- | -- | 3.00 | -0.0009 | -0.0009 | 0.0043 | -0.0035 | 1.62 | 1.28 | 3.63 | -- | -35.58 | -56.56 | -- | -- | 92.09 | 79.38 | -21.94 | -28.73 | 0.2911 | -9.29 | -- | -- | -11.99 | -4.01 | -3,856.50 | -- | -34.07 | -- |
| ZoomMed Inc | 154.28k | 1.46m | 2.16m | -- | -- | -- | 1.40 | 13.98 | 0.0107 | 0.0107 | 0.0011 | -0.0014 | 15.76 | -- | 46.89 | -- | 14,863.23 | -- | -- | -- | -- | -- | 943.16 | -- | -- | -- | -- | -- | 3,951.93 | -- | 114.30 | -- | -- | -- |
| EvokAI Creative Labs Inc | 0.00 | -13.65m | 2.28m | -- | -- | -- | -- | -- | -0.1467 | -0.1467 | 0.00 | -0.0105 | 0.00 | -- | 0.3277 | -- | -189.56 | -1,785.96 | -197.78 | -3,725.86 | -- | -- | -- | -- | -- | -137.12 | -- | -- | -- | -- | -3,520.74 | -- | -- | -- |
| Binovi Technologies Corp | -100.00bn | -100.00bn | 2.31m | 0.00 | -- | -- | -- | -- | -- | -- | -- | -0.0873 | -- | -- | -- | -- | -- | -170.25 | -- | -254.88 | -- | 71.98 | -- | -1,712.66 | 0.3215 | -- | -- | -- | -74.42 | 13.94 | -79.12 | -- | -- | -- |
| Lattice Biologics Ltd | 2.19m | -1.34m | 4.24m | -- | -- | -- | -- | 1.93 | -0.0105 | -0.0105 | 0.0172 | 0.0011 | 1.01 | 3.83 | 8.70 | -- | -61.69 | -- | -- | -- | 28.53 | -- | -61.08 | -- | 0.00 | -1.02 | 0.00 | -- | 12.60 | -- | -46.52 | -- | -- | -- |
| SQI Diagnostics Inc | 3.04m | -19.13m | 6.18m | 55.00 | -- | -- | -- | 2.03 | -0.0483 | -0.0483 | 0.0077 | -0.035 | 0.286 | 3.23 | 3.91 | -- | -179.74 | -147.99 | -- | -264.33 | 10.97 | 48.25 | -628.52 | -400.28 | 0.1193 | -3.03 | 24.07 | -- | 783.53 | 52.95 | -75.46 | -- | 42.57 | -- |
